Quest Diagnostics Incorporated (DGX) — Form 8-K: Current report

Quest Diagnostics Incorporated filed a current report on October 6, 2026, announcing that Catherine T. Doherty will retire in July 2027. Effective November 1, 2026, Ms. Doherty will transition to a new role as Executive Vice President with responsibilities including health systems, the Corewell Health joint venture, and Project Nova. Her compensation remains unchanged with a base salary of $650,000, an annual incentive target of 80%, and an equity award of restricted stock units with a target value of $1,200,000 granted on November 3, 2026.